Greetings, Thanks to all of you who have emailed your senators. Some have asked if there is anything else we can be doing. The answer is YES! We can call...
Haematologica, Vol 93, Issue 7, 1039-1048 doi:10.3324/haematol.12402 The effect of FK506 on transforming growth factor ? signaling and apoptosis in chronic...
Blood First Edition Paper, prepublished online June 30, 2008; DOI 10.1182/blood-2007-12-130781. The BH3-only mimetic ABT-737 synergizes the anti-neoplastic...
Blood First Edition Paper, prepublished online June 30, 2008; DOI 10.1182/blood-2008-02-140673. Toll-like receptors: lessons to learn from normal and malignant...
Relative value Of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia. Laura Z Rassenti, Sonia...
Long-term clinical remission of a patient with chronic lymphocytic leukemia using alternative treatment option: Cottonseed oil (gossypol). W M Politzer ...
CD31 density is a novel risk factor for patients with B-cell chronic lymphocytic leukaemia. T Mainou-Fowler, A Porteous, A Nicolle, SJ Proctor, JJ Anderson,...
Cancer Research 68, 5414-5422, July 1, 2008. doi: 10.1158/0008-5472.CAN-07-5601 GM1 Expression of Non-Hodgkin's Lymphoma Determines Susceptibility to Rituximab...
NEWS-MEDICAL.NET 24/06/2008 Discovery of an important factor in the development of B-cell lymphomas Researchers at National Jewish Medical and Research...
Blood First Edition Paper, prepublished online July 3, 2008; DOI 10.1182/blood-2008-05-157131. Mcl-1 expression has in vitro and in vivo significance in...
J. Biol. Chem, 10.1074/jbc.M802511200 ABT-737 induces expression of the death receptor 5 and sensitizes human cancer cells to TRAIL-induced apoptosis Jin H....
Greetings, Many very good points made here and a reminder to patients that we need to be careful about generalizing and assuming that what is effective for one...
Greetings, Updated the following topic in response to a question received off list: http://www.lymphomation.org/insurance.htm#no_insurance All the best, ~ Karl...
Greetings, Much progress has been made towards understanding cancer cells - what makes them different from normal cells of the same type, and how to design...
Alemtuzumab for B-cell chronic lymphocytic leukemia. T Robak Expert Rev Anticancer Ther, July 1, 2008; 8(7): 1033-51. Department of Hematology, Medical...
In vitro and in vivo evaluation of direct rhenium-188-labeled anti-CD52 monoclonal antibody alemtuzumab for radioimmunotherapy of B-cell chronic lymphocytic...
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the...
BCL-2 phosphorylation modulates sensitivity to the BH3 mimetic GX15-070 (Obatoclax) and reduces its synergistic interaction with bortezomib in chronic...
Direct and complement dependent cytotoxicity in CLL cells from patients with high-risk early-intermediate stage chronic lymphocytic leukemia (CLL) treated with...
JCO Early Release, published online ahead of print Jul 7 2008 Journal of Clinical Oncology, 10.1200/JCO.2007.14.6571 Survival Patterns Among Lymphoma Patients...
Lenalidomide for Relapsed Chronic Lymphocytic Leukemia Patients Lenalidomide, given as a continuous daily oral dose, showed antitumor activity in one third of...
Pricey Drugs Put Squeeze on Doctors By MARILYN CHASE July 8, 2008; Page A1 SAN FRANCISCO -- Long a burden for patients, hyperexpensive cancer drugs are causing...
And with it, our extension for RIT!!! Kennedy Votes as Medicare Bill Passes By THE ASSOCIATED PRESS Published: July 9, 2008 Filed at 6:22 p.m. ET Skip to next...
Congress Extends 2007 Reimbursement Rates for Radioimmunotherapies for 18 Months http://tinyurl.com/5sgg5c All the best and thanks for your efforts! ......
Here's some information on Bortezomib (Velcade), a targeted therapy approved for Mantle cell lymphoma. ... describes possible synergy with dexamethasone....
Hi Anna, I just wanted to say thanks for posting this item and note that Dr. Randy Gascoyne is highly respected by his peers. When he talks the leaders in ...
Nanoparticles Take On Tumors By Rachel Zelkowitz ScienceNOW Daily News 8 July 2008 The drugs cancer patients take to destroy their tumors also cause...
Having problems with message search?
Fill out this form to ensure your group is one of the first to be migrated to the new message search system.
